Peripheral Blood CD34+ Percentage at Hematological Recovery after Chemotherapy Is a Good Early Predictor of Harvest: A Single-Center Experience-Reference-Cited by-同舟云学术

Peripheral Blood CD34+ Percentage at Hematological Recovery after Chemotherapy Is a Good Early Predictor of Harvest: A Single-Center Experience

Published:2014-05 Issue:5 Volume:20 Page:717-723
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Sorasio Roberto,Bonferroni Margherita,Grasso Mariella,Strola Giuliana,Rapezzi Davide,Marenchino Dario,Di Marco Cristina,Castellino Claudia,Mattei Daniele,Mordini Nicola,Fiore Francesca,Celeghini Ivana,Borra Anna,Ghiglia Annalisa,Gallamini Andrea

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. How I treat patients who mobilize hematopoietic stem cells poorly;To;Blood,2011

2. Proposed definition of “poor mobilizer” in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo;Olivieri;Bone Marrow Transplant,2012

3. AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data;Calandra;Bone Marrow Transplant,2008

4. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma;DiPersio;Blood,2009

5. Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data;Duarte;Bone Marrow Transplant,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focus on: Prognostic scores to predict stem cell mobilization;Transfusion and Apheresis Science;2024-06

2. How to manage poor mobilisers;Transfusion and Apheresis Science;2024-06

3. Presence of Promyelocytes in Peripheral Blood as a Novel Predictor of Optimal Timing for Single-Step Peripheral Blood Stem Cell Collection;Journal of Nippon Medical School;2021-02-15

4. Economic Evaluation of Administration of Plerixafor Based on CD34 Positive Cell Measurement;Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences);2020-07-10

5. The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma;Bone Marrow Transplantation;2019-11-25